Multi Medika Valuation
| MMIX Stock | 75.00 1.00 1.32% |
Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. Multi Medika Interna last-minute Real Value cannot be determined due to lack of data. The latest price of Multi Medika Interna is USD75.0. Our model forecasts the value of Multi Medika Interna from analyzing the firm fundamentals such as Profit Margin of 0.14 %, return on equity of 1.81, and Shares Owned By Insiders of 7.00 % as well as examining its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that Multi Medika's price fluctuation is out of control at this time. Calculation of the real value of Multi Medika Interna is based on 3 months time horizon. Increasing Multi Medika's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Multi Medika's intrinsic value may or may not be the same as its current market price of 75.00, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 75.0 | Real 0.0 | Hype 0.0 | Naive 76.92 |
The intrinsic value of Multi Medika's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Multi Medika's stock price.
Estimating the potential upside or downside of Multi Medika Internasional helps investors to forecast how Multi stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Multi Medika more accurately as focusing exclusively on Multi Medika's fundamentals will not take into account other important factors: Multi Medika Total Value Analysis
Multi Medika Internasional is now forecasted to have takeover price of 0 with market capitalization of 1.27 T, debt of , and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Multi Medika fundamentals before making investing decisions based on enterprise value of the companyMulti Medika Asset Utilization
One of the ways to look at asset utilization of Multi is to check how much profit was generated for every dollar of assets it reports. Multi Medika Internasional makes use of its assets almost 0.37 %, making USD0.003714 for each dollar of assets held by the firm. A positive asset utilization conveys that the company is slightly more effective with each dollar of assets it secures. Strictly speaking, asset utilization of Multi Medika shows how effective it operates for each dollar spent on its assets.Multi Medika Ownership Allocation
The market capitalization of Multi Medika Internasional is USD1.27 Trillion. Multi Medika Internasional secures 7.0 % of its outstanding shares held by insiders and 0.0 % owned by institutional investors. Please take into account that even companies with profitable outlook can generate negative future returns on their equity. If the true value of the firm is less than the current market value, you may not be able generate positive returns on investment in the long run.About Multi Medika Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Multi Medika Internasional. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Multi Medika Interna based exclusively on its fundamental and basic technical indicators. By analyzing Multi Medika's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Multi Medika's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Multi Medika. We calculate exposure to Multi Medika's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Multi Medika's related companies.8 Steps to conduct Multi Medika's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Multi Medika's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Multi Medika's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Multi Medika's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Multi Medika's revenue streams: Identify Multi Medika's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Multi Medika's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Multi Medika's growth potential: Evaluate Multi Medika's management, business model, and growth potential.
- Determine Multi Medika's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Multi Medika's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Other Information on Investing in Multi Stock
Multi Medika financial ratios help investors to determine whether Multi Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Multi with respect to the benefits of owning Multi Medika security.